Agenus Inc. (AGEN) is a publicly traded Healthcare sector company. As of October 8, 2026, AGEN trades at $7.63 with a market cap of $338.26M and a P/E ratio of 3.28. AGEN moved +0.73% today. Year to date, AGEN is +134.37%; over the trailing twelve months it is +78.12%. Its 52-week range spans $1.38 to $10.31. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces AGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AGEN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $7.63 |
| Market Cap | $338.26M |
| P/E Ratio | 3.28 |
| EPS | $2.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.31 |
| 52-Week Low | $1.38 |
| Volume | 3.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $132.69M |
| Net Income | $91.94M |
| Gross Margin | 0.00% |
4 analysts cover AGEN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.